Dermapharm
DMP.F
#4478
Rank
C$3.63 B
Marketcap
C$73.41
Share price
-2.89%
Change (1 day)
30.72%
Change (1 year)

Financial Statements

Thumbnail Dermapharm Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2025

Financial Statement 2025

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2024

Financial Statement 2024

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2023

Financial Statement 2023

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2022

Financial Statement 2022

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2021

Financial Statement 2021

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2020

Financial Statement 2020

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2019

Financial Statement 2019

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2018

Financial Statement 2018

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2017

Financial Statement 2017

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2017

Financial Statement 2017

Language: German

View Financial Statement
Thumbnail Dermapharm Financial Statement 2016

Financial Statement 2016

Language: English

View Financial Statement
Thumbnail Dermapharm Financial Statement 2016

Financial Statement 2016

Language: German

View Financial Statement